Inari Medical, Inc.Inari Medical, Inc.Inari Medical, Inc.

Inari Medical, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.03 B‬USD
−1.35USD
‪−1.64 M‬USD
‪493.63 M‬USD
‪50.06 M‬
Beta (1Y)
0.51
Employees (FY)
‪1.3 K‬
Change (1Y)
+200 +18.18%
Revenue / Employee (1Y)
‪379.72 K‬USD
Net income / Employee (1Y)
‪−1.26 K‬USD

About Inari Medical, Inc.


CEO
Andrew J. Hykes
Headquarters
Irvine
Founded
2011
FIGI
BBG009J8K7M0
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NARI is 51.39 USD — it has decreased by −0.87% in the past 24 hours. Watch Inari Medical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inari Medical, Inc. stocks are traded under the ticker NARI.
NARI stock has risen by 5.89% compared to the previous week, the month change is a 21.83% rise, over the last year Inari Medical, Inc. has showed a −5.72% decrease.
We've gathered analysts' opinions on Inari Medical, Inc. future price: according to them, NARI price has a max estimate of 86.00 USD and a min estimate of 48.00 USD. Watch NARI chart and read a more detailed Inari Medical, Inc. stock forecast: see what analysts think of Inari Medical, Inc. and suggest that you do with its stocks.
NARI reached its all-time high on Mar 11, 2021 with the price of 127.42 USD, and its all-time low was 36.73 USD and was reached on Apr 22, 2024. View more price dynamics on NARI chart.
See other stocks reaching their highest and lowest prices.
NARI stock is 5.08% volatile and has beta coefficient of 0.51. Track Inari Medical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Inari Medical, Inc. there?
Today Inari Medical, Inc. has the market capitalization of ‪3.01 B‬, it has increased by 7.14% over the last week.
Yes, you can track Inari Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Inari Medical, Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
NARI earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.12 USD resulting in a 27.69% surprise. The estimated earnings for the next quarter are −0.02 USD per share. See more details about Inari Medical, Inc. earnings.
Inari Medical, Inc. revenue for the last quarter amounts to ‪153.39 M‬ USD, despite the estimated figure of ‪150.69 M‬ USD. In the next quarter, revenue is expected to reach ‪160.48 M‬ USD.
NARI net income for the last quarter is ‪−18.37 M‬ USD, while the quarter before that showed ‪−31.35 M‬ USD of net income which accounts for 41.41% change. Track more Inari Medical, Inc. financial stats to get the full picture.
No, NARI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has ‪1.30 K‬ employees. See our rating of the largest employees — is Inari Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inari Medical, Inc. EBITDA is ‪−15.14 M‬ USD, and current EBITDA margin is 1.44%. See more stats in Inari Medical, Inc. financial statements.
Like other stocks, NARI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inari Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inari Medical, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inari Medical, Inc. stock shows the neutral signal. See more of Inari Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.